136 related articles for article (PubMed ID: 30321778)
1. Design, and facile synthesis of 1,3 diaryl-3-(arylamino)propan-1-one derivatives as the potential alpha-amylase inhibitors and antioxidants.
Bashary R; Khatik GL
Bioorg Chem; 2019 Feb; 82():156-162. PubMed ID: 30321778
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, α-amylase inhibitory potential and molecular docking study of indole derivatives.
Taha M; Baharudin MS; Ismail NH; Imran S; Khan MN; Rahim F; Selvaraj M; Chigurupati S; Nawaz M; Qureshi F; Vijayabalan S
Bioorg Chem; 2018 Oct; 80():36-42. PubMed ID: 29864686
[TBL] [Abstract][Full Text] [Related]
3. A facile approach synthesis of benzoylaryl benzimidazole as potential α-amylase and α-glucosidase inhibitor with antioxidant activity.
Aroua LM; Almuhaylan HR; Alminderej FM; Messaoudi S; Chigurupati S; Al-Mahmoud S; Mohammed HA
Bioorg Chem; 2021 Sep; 114():105073. PubMed ID: 34153810
[TBL] [Abstract][Full Text] [Related]
4. Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics.
Shahzad D; Saeed A; Larik FA; Channar PA; Abbas Q; Alajmi MF; Arshad MI; Erben MF; Hassan M; Raza H; Seo SY; El-Seedi HR
Molecules; 2019 Apr; 24(8):. PubMed ID: 30999646
[TBL] [Abstract][Full Text] [Related]
5. In silico molecular docking and in vitro antidiabetic studies of dihydropyrimido[4,5-a]acridin-2-amines.
Bharathi A; Roopan SM; Vasavi CS; Munusami P; Gayathri GA; Gayathri M
Biomed Res Int; 2014; 2014():971569. PubMed ID: 24991576
[TBL] [Abstract][Full Text] [Related]
6. 2-Aryl benzimidazoles: Synthesis, In vitro α-amylase inhibitory activity, and molecular docking study.
Adegboye AA; Khan KM; Salar U; Aboaba SA; Kanwal ; Chigurupati S; Fatima I; Taha M; Wadood A; Mohammad JI; Khan H; Perveen S
Eur J Med Chem; 2018 Apr; 150():248-260. PubMed ID: 29533872
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of alpha amylase inhibitors based on privileged indole scaffold.
Noreen T; Taha M; Imran S; Chigurupati S; Rahim F; Selvaraj M; Ismail NH; Mohammad JI; Ullah H; Javid MT; Nawaz F; Irshad M; Ali M
Bioorg Chem; 2017 Jun; 72():248-255. PubMed ID: 28482265
[TBL] [Abstract][Full Text] [Related]
8. Alpha-amylase as molecular target for treatment of diabetes mellitus: A comprehensive review.
Kaur N; Kumar V; Nayak SK; Wadhwa P; Kaur P; Sahu SK
Chem Biol Drug Des; 2021 Oct; 98(4):539-560. PubMed ID: 34173346
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors.
Toumi A; Boudriga S; Hamden K; Sobeh M; Cheurfa M; Askri M; Knorr M; Strohmann C; Brieger L
Bioorg Chem; 2021 Jan; 106():104507. PubMed ID: 33288322
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation and molecular docking studies of novel benzimidazole derivatives.
Singh G; Singh A; Verma RK; Mall R; Azeem U
Comput Biol Chem; 2018 Feb; 72():45-52. PubMed ID: 29346072
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in silico studies of fluorinated 2,3-disubstituted thiazolidinone-pyrazoles as potential α-amylase inhibitors and antioxidant agents.
Ganavi D; Ramu R; Kumar V; Patil SM; Martiz RM; Shirahatti PS; Sathyanarayana R; Poojary B; Holla BS; Poojary V; Kumari KPN; Shivachandra JC
Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100342. PubMed ID: 34923670
[TBL] [Abstract][Full Text] [Related]
12. Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking in silico.
Jhong CH; Riyaphan J; Lin SH; Chia YC; Weng CF
Biofactors; 2015; 41(4):242-51. PubMed ID: 26154585
[TBL] [Abstract][Full Text] [Related]
13. Novel cyclic thiourea derivatives of aminoalcohols at the presence of AlCl
Sujayev A; Taslimi P; Garibov E; Karaman M; Mahdi Zangeneh M
Bioorg Chem; 2020 Nov; 104():104216. PubMed ID: 32911191
[TBL] [Abstract][Full Text] [Related]
14. New triazinoindole bearing thiazole/oxazole analogues: Synthesis, α-amylase inhibitory potential and molecular docking study.
Rahim F; Tariq S; Taha M; Ullah H; Zaman K; Uddin I; Wadood A; Khan AA; Rehman AU; Uddin N; Zafar S; Shah SAA
Bioorg Chem; 2019 Nov; 92():103284. PubMed ID: 31546207
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in silico inhibition properties of fucoidan against α-amylase and α-D-glucosidase with relevance to type 2 diabetes mellitus.
S LS; Raghu C; H A A; P A
Carbohydr Polym; 2019 Apr; 209():350-355. PubMed ID: 30732817
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of theophylline containing variant acetylene derivatives as α-amylase inhibitors.
Ruddarraju RR; Kiran G; Murugulla AC; Maroju R; Prasad DK; Kumar BH; Bakshi V; Reddy NS
Bioorg Chem; 2019 Nov; 92():103120. PubMed ID: 31525527
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of α-amylase and α-glucosidase inhibitory potential of Zea mays Linnaeus (Poaceae), Stigma maydis aqueous extract: An in vitro assessment.
Sabiu S; O'Neill FH; Ashafa AOT
J Ethnopharmacol; 2016 May; 183():1-8. PubMed ID: 26902829
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Evaluation of a Series of Oleanolic Acid Saponins as α-Glucosidase and α-Amylase Inhibitors.
Guo T; Wu S; Guo S; Bai L; Liu Q; Bai N
Arch Pharm (Weinheim); 2015 Sep; 348(9):615-28. PubMed ID: 26207761
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of sulpha drug based hydroxytriazene derivatives: Anti-diabetic, antioxidant, anti-inflammatory activity and their molecular docking studies.
Sharma P; Dayma V; Dwivedi A; Baroliya PK; Tripathi IP; Vanangamudi M; Chauhan RS; Goswami AK
Bioorg Chem; 2020 Mar; 96():103642. PubMed ID: 32062065
[TBL] [Abstract][Full Text] [Related]
20. A New Series of Salicylic Acid Derivatives as Non-saccharide α-Glucosidase Inhibitors and Antioxidants.
Chen J; Lu W; Chen H; Bian X; Yang G
Biol Pharm Bull; 2019 Feb; 42(2):231-246. PubMed ID: 30504654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
